Patients with lung disease from A1AT deficiency are currently being treated with standard medical therapy (22), intravenous augmentation therapy, or require lung transplantation for respiratory failure (23). Here, SERPINA1 is linked to hyperinsulinemic hypoglycemia, familial, 4.